GC Genome Corporation (KOSDAQ:340450)
7,700.00
+70.00 (0.92%)
At close: Dec 5, 2025
GC Genome Revenue
GC Genome had revenue of 8.84B KRW in the quarter ending September 30, 2025, with 45.98% growth. This brings the company's revenue in the last twelve months to 30.79B. In the year 2024, GC Genome had annual revenue of 25.89B, down -5.15%.
Revenue (ttm)
30.79B
Revenue Growth
-5.15%
P/S Ratio
5.91
Revenue / Employee
n/a
Employees
n/a
Market Cap
182.11B
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Samsung Biologics | 5,504.84B |
| Celltrion | 3,895.99B |
| ALTEOGEN | 202.18B |
| ABL Bio | 88.44B |
| SK Biopharmaceuticals | 675.41B |
| Yuhan | 2,136.67B |
| LigaChem Biosciences | 159.27B |
| HLB Co., Ltd. | 80.73B |